Falling birth rates reveal a deeper social problem: many people who want children feel blocked by economic, housing, gender, ...
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results